Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Adolescent Obesity and Midlife Cancer Risk

Findings from a population-based cohort study
05 Feb 2020
Cancer in Special Situations / Population;  Epidemiology/Etiology/Cancer Prevention

A group of researchers from Israel point out in an article published online on 3 February 2020 in The Lancet Diabetes & Endocrinology that the increasing prevalence of adolescent obesity and the possible association between adolescent body-mass index (BMI) and cancer incidence might increase the future burden of obesity-related cancers.

The study team wrote in the background that obesity has been established as a causal factor for several types of cancer. Adolescent obesity is increasing worldwide. Therefore, they examined associations between measured BMI at age 17 years and cancer incidence, and with mortality among those who developed cancer.

In a population-based cohort of adolescents in Israel, height and weight were measured at pre-recruitment mandatory medical examination during a period from 1967 to 2010. The BMI was classified according to US Center for Disease Control and Prevention percentiles. The researchers applied Cox proportional hazard models to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) for incident cases of cancer using the 5th–49th BMI percentile group as a reference.

The primary outcome was any cancer diagnosis between January 1967 and December 2012, as recorded in the Israeli National Cancer Registry. Participants with a diagnosis of cancer at baseline, before military recruitment assessment, were excluded from this analysis. The secondary outcome of this study was all-cause mortality among cohort members who had cancer, between January 1967 and December 2017.

Of the 2 458 170 participants examined during the study period, 160 040 were excluded. There were 2 298 130 participants of which 928 110 were women and 1 370 020 were men. During 29 542 735 person-years of follow-up in men, 26 353 incident cases of cancer were recorded and in 18 044 863 person-years of follow-up in women, 29 488 incident cases of cancer were recorded.

Cancer incidence increased gradually across BMI percentiles. The adjusted HR was 1.26 (95% CI 1.18–1.35) among men with adolescent obesity. Among women, the study team found no association between obesity and overall cancer, driven by inverse associations of obesity with cervical and breast cancers. When these cancers were excluded, the adjusted HR for cancer was 1.27 (1.13–1.44) among women with adolescent obesity.

In both sexes, high BMI (≥85th percentile) was associated with an increased cancer risk after 10 years. This association was accentuated in the late period of the cohort versus the early period of the cohort.

The BMI was positively associated with a higher risk of mortality. The projected population attributable risk for high BMI was 5.1% (4.2–6.1) for men and 5.7% (4.2–7.3) for women. 

The authors concluded that BMI among adolescents could constitute an important intervention target for cancer prevention.

 

Reference

Furer A, Afek A, Sommer A, et al. Adolescent obesity and midlife cancer risk: a population-based cohort study of 2.3 million adolescents in Israel. The Lancet Diabetes & Endocrinology; Published online 3 February 2020. DOI: https://doi.org/10.1016/S2213-8587(20)30019-X

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings